Cordis and BrosMed launch ceremony for the localization strategy at CIIE China
Release time:
2023-11-09
The Sixth China International Import Expo (CIIE) kicked off in Shanghai on November 5, 2023, As one of the world’s largest import-themed exhibitions, the CIIE attract a diverse range of exhibitors and enterprises to participate from across the world for global trade and economic cooperation.
The Sixth China International Import Expo (CIIE) kicked off in Shanghai on November 5, 2023, As one of the world’s largest import-themed exhibitions, the CIIE attract a diverse range of exhibitors and enterprises to participate from across the world for global trade and economic cooperation.
Through the CIIE, Cordis and BrosMed Medical seize this opportunity to launch ceremony for the localization strategy aim to deepen “Chinese Wisdom, Global Co-creation,” and promote the innovation ecosystem in the China market to empower grassroots healthcare.
This marks Cordis’ first step toward achieving local manufacturing in China. In April of this year, Cordis had already partnered with BrosMed Medical Co., Ltd. to jointly implement Cordis’ first Marketing Authorization Holder (MAH) project in China. They signed agreements for commissioned research and development and production of the SABER 0.014” PTA balloon dilatation catheter.
Mr. Cai Yulun, General Manager of Cordis China, said, ” Today is just the starting point. In the future, we look forward to continuing to work with BrosMed Medical to combine the global wisdom with local innovation to create a larger innovation ecosystem to support the development of healthcare.”
Mr. Benny Lee, CEO of BrosMed Medical, said, “As a representative of outstanding medical device manufacturers in China, BrosMed Medical has been cooperating with Cordis for over six years. We will work with Cordis’ global team to exert our strength on product research and development, providing more innovative products for global patients and creating a successful example of close cooperation between international brands and Chinese manufacturers.”
Cordis and BrosMed Medical will continue to uphold the mutual original commitment to innovation, maintain a patient-centered philosophy, persistently cultivate in the field of vascular intervention, and convey care to vascular disease patients worldwide.
Join with Us!
Please fill out this form and we will get in touch within 24 hours.
* Note: Please be sure to fill in the information accurately and keep the communication unblocked. We will get in touch with you as soon as possible.
More news
BrosMed Announced CE MDR Approval of New Generation Conger™ Plus Hydrophilic Guidewires
Designed for superior crossability and maneuverability in peripheral interventions, Conger Plus now offers 116 models with expanded sizes (OD 0.018'' to 0.038'') and lengths (up to 300cm).
2025-04-28
BrosMed to Showcase Innovative Solutions for CHIP PCI at EuroPCR 2025
Date: May 20-23, 2025 Venue: Palais des Congrès de Paris, Paris, France Booth No.: M20
2025-04-15
"Experience TCTAP 2025: Join Us with BrosMed!"
Save the Date April 23–26, 2025 and visit us at Booth #D41 to explore more highlights!
2025-04-08
Webinar Invitation | Innovations and Novel Strategies in CHIP PCI
Mark your calendar: Wednesday, March 26 🕒 18:00-19:30 (Beijing Time) | 11:00-12:30 (CET)
2025-03-19
On February 10, BrosMed and Cordis signed an agreement for the exclusive distribution of VaSecure™, BrosMed’s next-generation drug-coated peripheral balloon catheter in the China market.
2025-02-12